HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Propentofylline

HCID 4938
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
55242-55-2
Standard SMILES
CCCn1cnc2c1c(=O)n(CCCCC(C)=O)c(=O)n2C
InChIKey
RBQOQRRFDPXAGN-UHFFFAOYSA-N
Molecular formula
C15H22N4O3
Average molar mass
306.36 g/mol
Monoisotopic mass
306.16919058

Overview

Propentofylline is an oxopurine.

Names & identifiers

Preferred name
Propentofylline
IUPAC
3-methyl-1-(5-oxohexyl)-7-propylpurine-2,6-dione
English name
PROPENTOFYLLINE
Molecular formula
C15H22N4O3
Molecular weight
306.36

Names & synonyms

propentofylline55242-55-2PropentophyllineHWA-285HWA 2853,7-Dihydro-3-methyl-1-(5-oxohexyl)-7-propyl-1H-purine-2,6-dionePropentofyllinumPropentofilinaDTXSID40451891H-Purine-2,6-dione, 3,7-dihydro-3-methyl-1-(5-oxohexyl)-7-propyl-NSC-7524245RTA398U4H
Show more names
hoe-285karsivanHOE-285:Hextol:KarsivanPROPENTOFYLLINE USP/EP/BPPropentofylline, 10 mM in DMSO
DTXCID20251891-(5'-oxohexyl)-3-methyl-7-propylxanthineRefChem:869635N06BC023-methyl-1-(5-oxohexyl)-7-propyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione611-242-7HextolAlbert-285

Database identifiers

CAS
55242-55-2
PubChem CID
4938
DTXSID
DTXSID4045189
ChEMBL
CHEMBL1079905
ChEBI
CHEBI:32061
UNII
5RTA398U4H
EC Number
611-242-7
Nikkaji
J22.661K

Properties

Computed structural propertiesFilling in

XLogP
0.7
Topological polar surface area
75.5 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
4
Rotatable bonds
7
Heavy atoms
22
Formal charge
0
Complexity
454

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
Human DrugsPharmaceuticals
Animal DrugsPharmaceuticals -> UK Veterinary Medicines Directorate List
Collision Cross Section · 2 items

166.55 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

168.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
64 · 64-66°C
Boiling point
541.4 · 541.4±56.0 °C(Predicted)
Density
1.25 · 1.25±0.1 g/cm3(Predicted)
storage temp.
-20 °C · Sealed in dry,Store in freezer, under -20°C
solubility
2 O: · H2O: soluble12.4mg/mL
pka
0.58 · 0.58±0.70(Predicted)
form
solid
color
white
Water Solubility
2 O: · H2O: 12.4mg/mL
InChI
1S/C15H22N4O3/c1-4-8-18-10-16-13-12(18)14(21)19(15(22)17(13)3)9-6-5-7-11(2)20/h10H,4-9H2,1-3H3
InChIKey
RBQOQRRFDPXAGN-UHFFFAOYSA-N
SMILES
CCCn1cnc2N(C)C(=O)N(CCCCC(C)=O)C(=O)c12
EWG's Food Scores
1 · 1
FDA UNII
5 RTA398U4H · 5RTA398U4H
ATC code
6 BC02 · N06BC02
UNSPSC Code
41106305 · 41106305
NACRES
77 · NA.77
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302+H312+H332
Precautionary statements
261 · P261-P264-P280-P301+P312-P302+P352+P312-P304+P340+P312
PPE
95 · dust mask type N95 (US), Eyeshields, Gloves
Hazard Codes
Xn
Risk Statements
20 · 20/21/22
WGK Germany
3 · 3
RTECS
8438700 · UO8438700
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
4 DermalAcute · Acute Tox. 4 DermalAcute Tox. 4 InhalationAcute Tox. 4 Oral
Toxicity
50 in · LD50 in male, female mice, male, female rats (mg/kg): 900, 780, 1150, 940 orally; 168, 170, 180, 195 i.v.; 375, 346, 199, 196 i.p.; 450, 508, 400, 338 s.c. (Inazu)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 1.1% (1 of 95) of reports.

Warning

H302 (98.9%): Harmful if swallowed [Warning Acute toxicity, oral]

P260, P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P317, P319, P321, P330, P362+P364, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 95 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory InformationPropentofylline: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Hazard Classes and CategoriesAcute Tox. 4 (98.9%)

Safety data

PPE
dust mask type N95 (US), Eyeshields, Gloves
wgk
3
rtecs
UO8438700
Toxicity
LD50 in male, female mice, male, female rats (mg/kg): 900, 780, 1150, 940 orally; 168, 170, 180, 195 i.v.; 375, 346, 199, 196 i.p.; 450, 508, 400, 338 s.c. (Inazu)
risk_code
20/21/22
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn
Storage Class
11 - Combustible Solids
Hazard statements
H302+H312+H332
Hazard Classifications
Acute Tox. 4 DermalAcute Tox. 4 InhalationAcute Tox. 4 Oral
Precautionary statements
P261-P264-P280-P301+P312-P302+P352+P312-P304+P340+P312

Chemistry & industry

Pharmacology

ATC Code · 3 items

N - Nervous system

QN - Nervous system

QC - Cardiovascular system

Mechanism of Action · 1 item

Propentofylline is a xanthine derivative and phosphodiesterase inhibitor with purported neuroprotective effects. It inhibits both phosphodiesterase and adenosine uptake. Phosphodiesterase has shown to associated with age-related memory impairment and Alzheimer's disease. β-Amyloid protein 1–42 (β42) can induce apoptosis in the cultured hippocampal neurons, suggesting that it plays an important role in causing neurodegeneration in Alzheimer's disease. Propentofylline is also capable of activating a cAMP–PKA system, depressing the caspase cascade and modifying Bcl-2 family proteins. Propentofylline blocked both the apoptotic features induced by β42 and further induced an anti-apoptotic protein, Bcl-2. It suggests that the protection of propentofylline on the β42-induced neurotoxicity is caused by enhancing anti-apoptotic action through cAMP–PKA system.

MeSH Pharmacological Classification · 1 item

Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids.

Uses & manufacturing

Use ClassificationPharmaceuticals

Applications

DescriptionPropentofylline is a nootropic indicated for cerebrovascular disorders. Other indications currently under investigation include senile dementia, stroke and hypoxia.

UsesA c-AMP phosphodiesterase inhibitor. A nerve growth factor stimulator. An adenosine transport inhibitor. A non-selective adenosine receptor antagonist. Nootropic.

Upstream & downstream products

Upstream raw materials

1-Bromo-5-hexanone

Additional notes

DefinitionChEBI: Propentofylline is an oxopurine.

Related reactions

7 records
New reaction record
HRID 99394 reaction equation
HRID 99394As product
HRID 341795 reaction equation
HRID 341795As reactant
HRID 1602129 reaction equation
HRID 1602129As reactant
HRID 1738785 reaction equation
HRID 1738785As reactant
HRID 1738786 reaction equation
HRID 1738786As reactant
HRID 1738802 reaction equation
HRID 1738802As reactant
HRID 2259588 reaction equation
HRID 2259588As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes